ArticleThe British journal of dermatology2022

Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T-cell lymphoma: a retrospective single-centre case series.

N A Trum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.